FDA/CMS Collaboration: “Sleeper Group” Goes Public With Call For Real-World Evidence

US FDA, CMS and NIH are hoping to create a “single front door” for research. Article outlining collaboration on real-world evidence suggests one path forward.

More from US FDA

More from Agency Leadership